Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology.
about
Acquired pure red cell aplasia: updated review of treatmentAutoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: response to rituximab and cyclophosphamide.Autoimmune cytopenias in chronic lymphocytic leukemia, facts and mythsSuccessful management of multilineage autoimmune cytopenia complicated with severe infection and deep vein thrombosis in a patient with Hodgkin lymphoma post-autologous hematopoietic stem cell transplantation.Glycosphingolipids mediate pneumocystis cell wall β-glucan activation of the IL-23/IL-17 axis in human dendritic cells.Adjuvant chemotherapy for breast cancer in a patient with primary autoimmune neutropenia.Update on the diagnosis and treatment of Pneumocystis pneumonia.Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe Outcome.Thymoma with Concomitant Pure Red Cell Aplasia, Good's Syndrome and Myasthenia Gravis Responding to Rituximab.Rational management approach to pure red cell aplasia.Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma.Deferasirox treatment improved hematopoiesis and led to complete remission in a patient with pure red cell aplasia.Pure red cell aplasia complicating chronic lymphocytic leukemia: rapid response to high-dose methylprednisolone and rituximab.
P2860
Q24652253-A0BF69F1-6694-4748-BD3F-E6CB708761C5Q33395141-58841E11-3131-45F8-BFAF-87A2C06FFDFFQ33397611-2789F5B7-5BC1-49E8-9F44-E74CD463E7B5Q33412266-918164E0-AD69-474D-A735-6E12190E51AEQ33428417-1DE2F717-DE4D-4905-A254-9C22E8F95C68Q36110545-E5F92AAF-7D55-4DFA-8832-9D772CD66B81Q36611242-AF5D3EF3-5F27-4A58-954D-6350CB03A5FDQ37782191-ADB2A3CC-A916-40D9-A54B-9A61FBF7B37CQ37810067-F6000896-71EA-4A42-8156-3FFE222FD6E1Q37843939-4D3BD5F5-16F0-4616-BD03-15913EEDC156Q40079085-C0E5F1F6-2897-4AC0-9408-67E28F14B379Q42527402-C9856FDE-E0E7-423A-A519-3A446435F00BQ47584782-BE4DCF5B-5935-40D2-AAB7-833A38AF13C9Q50475827-2DA50ED5-5399-4CB4-9D7A-3C164CCB563EQ50484280-D2713A3C-EFDA-4CF0-8E33-0FEE614648F2Q50493924-7CA9073C-E4C4-4C9C-8592-CD3B117661BA
P2860
Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lack of clinical efficacy of r ...... ons for their pathophysiology.
@ast
Lack of clinical efficacy of r ...... ons for their pathophysiology.
@en
type
label
Lack of clinical efficacy of r ...... ons for their pathophysiology.
@ast
Lack of clinical efficacy of r ...... ons for their pathophysiology.
@en
prefLabel
Lack of clinical efficacy of r ...... ons for their pathophysiology.
@ast
Lack of clinical efficacy of r ...... ons for their pathophysiology.
@en
P2093
P1433
P1476
Lack of clinical efficacy of r ...... ons for their pathophysiology.
@en
P2093
Dearden CE
Dungarwalla M
Elebute MO
Gordon Smith EC
Ouwehand W
Pettengell R
P304
P356
10.1007/S00277-006-0202-5
P577
2006-11-23T00:00:00Z